INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 188 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,467,000 | -18.5% | 31,532 | 0.0% | 0.01% | -12.5% |
| Q2 2022 | $1,800,000 | -94.8% | 31,532 | -94.5% | 0.02% | -93.7% |
| Q1 2022 | $34,806,000 | +15.7% | 568,811 | -1.1% | 0.25% | +18.1% |
| Q4 2021 | $30,094,000 | +38.0% | 574,978 | -1.7% | 0.22% | +30.3% |
| Q3 2021 | $21,812,000 | +173.2% | 585,074 | +199.2% | 0.16% | +179.7% |
| Q2 2021 | $7,983,000 | +267.2% | 195,560 | +198.0% | 0.06% | +293.3% |
| Q4 2019 | $2,174,000 | +405.6% | 65,619 | +14.0% | 0.02% | +400.0% |
| Q3 2019 | $430,000 | -53.3% | 57,557 | -18.8% | 0.00% | -50.0% |
| Q2 2019 | $920,000 | +77.6% | 70,869 | +66.9% | 0.01% | +50.0% |
| Q1 2019 | $518,000 | – | 42,460 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
| Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
| DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
| Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
| Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
| Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |